Review



human trf2 with d1y5d  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc human trf2 with d1y5d
    a. Outline of DNaseI footprinting experiment. 32 P-labelled 5’ end highlighted by a red asterisk. Radiolabelled template is incubated with KU and DNAPKcs prior to the addition of Shelterin composed of TRF1, <t>TRF2,</t> RAP1, TIN2, POT1 and TPP1. DNase I digested products are then analysed by denaturing Urea-PAGE b-f. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. Nucleotides from the 5’ telomeric end indicated.
    Human Trf2 With D1y5d, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 34 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+trf2+with+d1y5d/TRF2+Rabbit+mAb/bio_rxiv__2024__12__28__630583-199-19-23
    Average 94 stars, based on 34 article reviews
    human trf2 with d1y5d - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Chromosome end protection by RAP1-mediated inhibition of DNA-PK"

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK

    Journal: bioRxiv

    doi: 10.1101/2024.12.28.630583

    a. Outline of DNaseI footprinting experiment. 32 P-labelled 5’ end highlighted by a red asterisk. Radiolabelled template is incubated with KU and DNAPKcs prior to the addition of Shelterin composed of TRF1, TRF2, RAP1, TIN2, POT1 and TPP1. DNase I digested products are then analysed by denaturing Urea-PAGE b-f. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. Nucleotides from the 5’ telomeric end indicated.
    Figure Legend Snippet: a. Outline of DNaseI footprinting experiment. 32 P-labelled 5’ end highlighted by a red asterisk. Radiolabelled template is incubated with KU and DNAPKcs prior to the addition of Shelterin composed of TRF1, TRF2, RAP1, TIN2, POT1 and TPP1. DNase I digested products are then analysed by denaturing Urea-PAGE b-f. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. Nucleotides from the 5’ telomeric end indicated.

    Techniques Used: Footprinting, Incubation, Binding Assay

    a. domain organisa-tion of RAP1 and TRF2. b-d. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. See figure S1 for mutant details. e. protein cross-linking analysis of RAP1 and KU in the presence of DNA. Proteins were mixed with crosslinker and the products of the reaction were separat-ed on a denaturing tris-acetate polyacrylamide gel and analysed by silver staining or immunoblotting as indicated. Arroheads mark the position of crosslinked species containing only KU, or KU and RAP1 as indicated f, g. as in b.
    Figure Legend Snippet: a. domain organisa-tion of RAP1 and TRF2. b-d. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. See figure S1 for mutant details. e. protein cross-linking analysis of RAP1 and KU in the presence of DNA. Proteins were mixed with crosslinker and the products of the reaction were separat-ed on a denaturing tris-acetate polyacrylamide gel and analysed by silver staining or immunoblotting as indicated. Arroheads mark the position of crosslinked species containing only KU, or KU and RAP1 as indicated f, g. as in b.

    Techniques Used: Footprinting, Binding Assay, Mutagenesis, Silver Staining, Western Blot

    a. Outline of the KU pulldown approach. See methods for details b-d. KU-bound proteins from reactions containing KU70/80, DNA-PKcs, XRCC4/LIG4, TRF2, RAP1 and template DNA unless indicated were separated by SDS-PAGE and immunoblotted as indicated. TRF2, RAP1 and LIG4 detected with anti-strep tag antibody, KU70 with anti-FLAG antibody. As shown in (b), associated of TRF2 with KU is mediated by template DNA e. Quantification of the percentage of telomeres involved in chromosome fusions per metaphase upon over-expression of mouse RAP1, RAP1 KR/DE and RAP1 R130E after Crispr- and Cre-mediated deletion of Rap1 and Apollo respectively in ApolloF/F Lig4+/+ MEFs. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics by ordinary One-way ANOVA. ‘ns’ not significant, ****P ≤ 0.0001. See Fig. S8 for further details. f. Quantification of the percentage of telomeres fused per metaphase upon Crispr-mediated deletion of Apollo in p53-/-RPE-1 cells with wildtype RAP1 or the RAP1 KR/DE mutant. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics as in (e). See Fig. S8 for further details g. Model for the direct inhibition of DNA-PK by TRF2/RAP1 at mammalian telomeres. When assembled on telomeric DNA, DNA-PK is bound by the RAP1 myb and BRCT domains, which acts as a circuit breaker that prevents DNA-PK from engaging LIG4.
    Figure Legend Snippet: a. Outline of the KU pulldown approach. See methods for details b-d. KU-bound proteins from reactions containing KU70/80, DNA-PKcs, XRCC4/LIG4, TRF2, RAP1 and template DNA unless indicated were separated by SDS-PAGE and immunoblotted as indicated. TRF2, RAP1 and LIG4 detected with anti-strep tag antibody, KU70 with anti-FLAG antibody. As shown in (b), associated of TRF2 with KU is mediated by template DNA e. Quantification of the percentage of telomeres involved in chromosome fusions per metaphase upon over-expression of mouse RAP1, RAP1 KR/DE and RAP1 R130E after Crispr- and Cre-mediated deletion of Rap1 and Apollo respectively in ApolloF/F Lig4+/+ MEFs. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics by ordinary One-way ANOVA. ‘ns’ not significant, ****P ≤ 0.0001. See Fig. S8 for further details. f. Quantification of the percentage of telomeres fused per metaphase upon Crispr-mediated deletion of Apollo in p53-/-RPE-1 cells with wildtype RAP1 or the RAP1 KR/DE mutant. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics as in (e). See Fig. S8 for further details g. Model for the direct inhibition of DNA-PK by TRF2/RAP1 at mammalian telomeres. When assembled on telomeric DNA, DNA-PK is bound by the RAP1 myb and BRCT domains, which acts as a circuit breaker that prevents DNA-PK from engaging LIG4.

    Techniques Used: SDS Page, Strep-tag, Over Expression, CRISPR, Mutagenesis, Inhibition

    Related Articles

    Footprinting:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Incubation:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Binding Assay:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Mutagenesis:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Silver Staining:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Western Blot:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    SDS Page:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Strep-tag:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Over Expression:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    CRISPR:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.

    Inhibition:

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK
    Article Snippet: Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).Recombinant human XRCC4 was detected with antibody C-4 (Santa Cruz sc-271087).. Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.. Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.Mouse β-actin was detected with primary antibody C4 (Cell Signaling #3700) and Goat anti-Mouse IgG horseradish peroxidase (31430, Invitrogen) secondary antibody.



    Similar Products

    94
    Cell Signaling Technology Inc human trf2 with d1y5d
    a. Outline of DNaseI footprinting experiment. 32 P-labelled 5’ end highlighted by a red asterisk. Radiolabelled template is incubated with KU and DNAPKcs prior to the addition of Shelterin composed of TRF1, <t>TRF2,</t> RAP1, TIN2, POT1 and TPP1. DNase I digested products are then analysed by denaturing Urea-PAGE b-f. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. Nucleotides from the 5’ telomeric end indicated.
    Human Trf2 With D1y5d, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+trf2+with+d1y5d/TRF2+Rabbit+mAb/bio_rxiv__2024__12__28__630583-199-19-23
    Average 94 stars, based on 1 article reviews
    human trf2 with d1y5d - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    a. Outline of DNaseI footprinting experiment. 32 P-labelled 5’ end highlighted by a red asterisk. Radiolabelled template is incubated with KU and DNAPKcs prior to the addition of Shelterin composed of TRF1, TRF2, RAP1, TIN2, POT1 and TPP1. DNase I digested products are then analysed by denaturing Urea-PAGE b-f. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. Nucleotides from the 5’ telomeric end indicated.

    Journal: bioRxiv

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK

    doi: 10.1101/2024.12.28.630583

    Figure Lengend Snippet: a. Outline of DNaseI footprinting experiment. 32 P-labelled 5’ end highlighted by a red asterisk. Radiolabelled template is incubated with KU and DNAPKcs prior to the addition of Shelterin composed of TRF1, TRF2, RAP1, TIN2, POT1 and TPP1. DNase I digested products are then analysed by denaturing Urea-PAGE b-f. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. Nucleotides from the 5’ telomeric end indicated.

    Article Snippet: Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.

    Techniques: Footprinting, Incubation, Binding Assay

    a. domain organisa-tion of RAP1 and TRF2. b-d. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. See figure S1 for mutant details. e. protein cross-linking analysis of RAP1 and KU in the presence of DNA. Proteins were mixed with crosslinker and the products of the reaction were separat-ed on a denaturing tris-acetate polyacrylamide gel and analysed by silver staining or immunoblotting as indicated. Arroheads mark the position of crosslinked species containing only KU, or KU and RAP1 as indicated f, g. as in b.

    Journal: bioRxiv

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK

    doi: 10.1101/2024.12.28.630583

    Figure Lengend Snippet: a. domain organisa-tion of RAP1 and TRF2. b-d. DNaseI footprinting of telomere end-binding complexes. Proteins omitted as indicated. See figure S1 for mutant details. e. protein cross-linking analysis of RAP1 and KU in the presence of DNA. Proteins were mixed with crosslinker and the products of the reaction were separat-ed on a denaturing tris-acetate polyacrylamide gel and analysed by silver staining or immunoblotting as indicated. Arroheads mark the position of crosslinked species containing only KU, or KU and RAP1 as indicated f, g. as in b.

    Article Snippet: Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.

    Techniques: Footprinting, Binding Assay, Mutagenesis, Silver Staining, Western Blot

    a. Outline of the KU pulldown approach. See methods for details b-d. KU-bound proteins from reactions containing KU70/80, DNA-PKcs, XRCC4/LIG4, TRF2, RAP1 and template DNA unless indicated were separated by SDS-PAGE and immunoblotted as indicated. TRF2, RAP1 and LIG4 detected with anti-strep tag antibody, KU70 with anti-FLAG antibody. As shown in (b), associated of TRF2 with KU is mediated by template DNA e. Quantification of the percentage of telomeres involved in chromosome fusions per metaphase upon over-expression of mouse RAP1, RAP1 KR/DE and RAP1 R130E after Crispr- and Cre-mediated deletion of Rap1 and Apollo respectively in ApolloF/F Lig4+/+ MEFs. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics by ordinary One-way ANOVA. ‘ns’ not significant, ****P ≤ 0.0001. See Fig. S8 for further details. f. Quantification of the percentage of telomeres fused per metaphase upon Crispr-mediated deletion of Apollo in p53-/-RPE-1 cells with wildtype RAP1 or the RAP1 KR/DE mutant. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics as in (e). See Fig. S8 for further details g. Model for the direct inhibition of DNA-PK by TRF2/RAP1 at mammalian telomeres. When assembled on telomeric DNA, DNA-PK is bound by the RAP1 myb and BRCT domains, which acts as a circuit breaker that prevents DNA-PK from engaging LIG4.

    Journal: bioRxiv

    Article Title: Chromosome end protection by RAP1-mediated inhibition of DNA-PK

    doi: 10.1101/2024.12.28.630583

    Figure Lengend Snippet: a. Outline of the KU pulldown approach. See methods for details b-d. KU-bound proteins from reactions containing KU70/80, DNA-PKcs, XRCC4/LIG4, TRF2, RAP1 and template DNA unless indicated were separated by SDS-PAGE and immunoblotted as indicated. TRF2, RAP1 and LIG4 detected with anti-strep tag antibody, KU70 with anti-FLAG antibody. As shown in (b), associated of TRF2 with KU is mediated by template DNA e. Quantification of the percentage of telomeres involved in chromosome fusions per metaphase upon over-expression of mouse RAP1, RAP1 KR/DE and RAP1 R130E after Crispr- and Cre-mediated deletion of Rap1 and Apollo respectively in ApolloF/F Lig4+/+ MEFs. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics by ordinary One-way ANOVA. ‘ns’ not significant, ****P ≤ 0.0001. See Fig. S8 for further details. f. Quantification of the percentage of telomeres fused per metaphase upon Crispr-mediated deletion of Apollo in p53-/-RPE-1 cells with wildtype RAP1 or the RAP1 KR/DE mutant. Data from 3 independent experiments, 10 metaphases per experiment (n = 30 total), with median. Statistics as in (e). See Fig. S8 for further details g. Model for the direct inhibition of DNA-PK by TRF2/RAP1 at mammalian telomeres. When assembled on telomeric DNA, DNA-PK is bound by the RAP1 myb and BRCT domains, which acts as a circuit breaker that prevents DNA-PK from engaging LIG4.

    Article Snippet: Mouse RAP1 was detected with antibody D9H4 (Rabbit mAb #5433), human RAP1 with A300-306A antibody (Bethyl Laboratories) mouse and human TRF2 with D1Y5D (Cell Signaling 13136), and Donkey anti-Rabbit IgG horseradish peroxidase (NA934V, Cytiva) or Goat anti-Rabbit IgG horseradish peroxidase (31460, Invitrogen) secondary antibodies.

    Techniques: SDS Page, Strep-tag, Over Expression, CRISPR, Mutagenesis, Inhibition